with local country regulations; analytics reports were established for performance measurement. Methods. 3. Methods- New User Engagement Features.
Engage Patients with Innovative Global Digital Patient Platform Helen Lee, Associate Director
Elizabeth Beatty, Cathy Florek, Cynthia Springer, Wen Shi, Zeshan Farooqui, Julia Weimer, Jessica Proszynski, Laurajean Conlon, Myra Abousabe, Robert Gray, John Stevens, Sandeep Bhat
Methods- New User Engagement Features
Objectives
Methods
In response to the trend that more patients and caregivers are consuming health related information online, new innovative features on the BMS StudyConnect website were added to better educate, connect and engage patients.
Results
Subscribe: Receive alerts
To make it more patient-centric, the original SharePoint site was re-platformed to a Salesforce.com that is mobile web browser friendly. To enhance functionality, new features (Registration, Subscription and Patient Screener, and Send to a Friend) were added. New business process were also instituted in collaborating with all stakeholders.
Register: Get contacted by a doctor’s office for a specific study
The website was re-platformed to be mobile friendly. New features and process improvements were instituted. Content was tailored to comply with local country regulations; analytics reports were established for performance measurement.
Share: Send and share with friends, family or your doctor.
www.bmsstudyconnect.com
Mobile-friendly!
1
Results
Results
With the rollout of new features, BMS StudyConnect website will allow patients to directly refer themselves from online to study sites and ultimately enables stronger engagement. Integrating with internal systems and enhanced data reporting will also allow teams to refine patient recruitment strategies for studies and indications.
6
3
2
7
4
Conclusions
Conclusions
The new Digital Patient Journey pathway can refer potential patients directly to study sites in their geographic area and to be contacted by the study site selected. The new “Subscribe” option also allows patients to receive future alerts of educational materials or study/site information.
If a study or a site is not available, a “Subscribe Option” allows a patient to “opt-in” to receive future educational materials. A simple Patient Screener is key to “filter out” non-qualified patients. The enhanced platform will also enable prospective patients to use StudyConnect in Germany and Canada in their local languages.
8
Results
5
Conclusions Through this new innovative Digital Patient Platform, time and cost associated with patient recruitment process are improved. With the new Referral and Subscription features, patients are more engaged as they are empowered to initiate the process.
A Patient Screener can pre-screen patients in order to refer pre-qualified patients to a study site. The innovative approach of integrating an internet tool with internal systems can effectively track digital patient recruitment status and provide metrics to measure performance and level of patient engagement.
9
To track patients from website to enrollment, analytics reports were established for performance measurement, enrollment tracking, and level of patient engagement. To expand to other regions, country-specific content was tailored to regional needs and to ensure compliance with local country regulations, language and study search support.
A patient who has contributed in this process will be more inclined to be engaged, empowered and adhere to it. 10
Disclosure Author(s) of this presentation have the following to disclose concerning possible financial or personal relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation:
Helen Lee (Bristol-Myers Squibb): Nothing to Disclose Elizabeth Beatty (Bristol-Myers Squibb): Nothing to Disclose Cathy Florek (Bristol-Myers Squibb): Nothing to Disclose Cynthia Springer (Bristol-Myers Squibb): Nothing to Disclose Wen Shi (Bristol-Myers Squibb): Nothing to Disclose Zeshan Farooqui (Bristol-Myers Squibb): Nothing to Disclose Julia Weimer (Bristol-Myers Squibb): Nothing to Disclose Jessica Proszynski (Bristol-Myers Squibb): Nothing to Disclose Laurajean Conlon (Bristol-Myers Squibb): Nothing to Disclose Myra Abousabe (Bristol-Myers Squibb): Nothing to Disclose Robert Gray (Bristol-Myers Squibb): Nothing to Disclose John Stevens (Bristol-Myers Squibb): Nothing to Disclose Sandeep Bhat (Cognizant Technology Solutions Corporation): Nothing to Disclose
11
